
Every year on April 17, World Hemophilia Day is observed worldwide to raise awareness of hemophilia and other inherited bleeding disorders. For many people, this condition is still misunderstood or diagnosed late, which can lead to serious complications. This day is a reminder that timely diagnosis, proper treatment, and ongoing care can help individuals with hemophilia live active and fulfilling lives.
Hemophilia is a rare genetic disorder where the blood does not clot properly due to the lack of specific clotting factors. This leads to prolonged bleeding even from minor injuries. In severe cases, bleeding can occur internally, especially in joints and muscles, causing pain, swelling, and long-term damage if not treated in time.
There are mainly two types:
In India, hemophilia A accounts for nearly 86% of cases, while hemophilia B makes up about 14%, highlighting how common factor VIII deficiency is in clinical practice.
This condition primarily affects males, while females are usually carriers, though they may also show mild symptoms in some cases.
Hemophilia is often considered rare, but the numbers tell a different story.
According to global survey data and clinical estimates (WFH and recent Indian projections):
A significant concern is disease severity. About 77% of patients have severe hemophilia, which means they are at higher risk of spontaneous bleeding episodes without injury.
The patient population is also relatively young, with a median age of around 20 years, which makes long-term management and early care even more critical.
Early signs of hemophilia are often overlooked. Recognizing them can make a significant difference:
If these symptoms appear repeatedly, it is important to seek medical evaluation without delay.
Here’s the key point, hemophilia cannot be cured, but it can be effectively managed.
Early diagnosis allows doctors to start preventive treatment, known as prophylaxis, which involves regular infusion of clotting factors. This reduces the risk of spontaneous bleeding and protects joints from long-term damage.
However, in India, access to such preventive care is still limited. Only about 7% of patients with severe hemophilia receive prophylactic treatment, which explains why many patients continue to experience avoidable complications.
At the same time, treatment is evolving. There is a gradual shift from on-demand care to preventive therapy, with newer options like emicizumab improving outcomes and convenience for patients.
Without proper management, hemophilia can lead to serious complications.
These insights highlight why regular monitoring and expert care are essential, not just treatment during emergencies.
Managing hemophilia goes beyond medical treatment. It requires a consistent and informed approach:
With the right care plan, individuals with hemophilia can attend school, work, and lead productive lives.
In India, awareness about hemophilia is still growing, especially outside urban areas. Many patients are diagnosed late, often after repeated bleeding episodes.
World Hemophilia Day plays a crucial role in changing this by encouraging early screening, improving understanding, and strengthening access to care.
At the same time, the healthcare ecosystem is evolving. The Indian hemophilia treatment landscape is expanding rapidly, with a projected growth rate of nearly 10% annually, improving the availability of advanced therapies over time.
Managing a lifelong condition like hemophilia requires more than just treatment, it requires consistent, informed, and compassionate care.
At Shivaay Hospicare, patients receive personalized evaluation and long-term management support tailored to their condition severity and lifestyle needs. Under the expert guidance of Dr. Reema Solanki Chauhan, the focus is on early diagnosis, preventive care, and minimizing complications through a structured treatment approach.
With the right medical support and awareness, individuals with hemophilia can lead safer, healthier, and more confident lives.
All rights reserved. © 2025–2026 Shivaay Hospicare.
Designed by Rang Digitech LLC.